Vivosim (NASDAQ: VIVS) Namkindtm Targets FDA's New Testing Bar
(MENAFN - GetNews) DALLAS TX., October 7, 2026 The FDA's push toward New Approach Methodologies (NAMs) could create an important opportunity for VivoSim Labs Inc. (NASDAQ: VIVS) and its ...
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →